Celecoxib enhances radiation response of secondary bone tumors of a human non-small cell lung cancer via antiangiogenesis in vivo. (Q53275350)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234531%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Celecoxib enhances radiation response of secondary bone tumors of a human non-small cell lung cancer via antiangiogenesis in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234531%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234531%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Frank Michael Klenke

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234531%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Amir Abdollahi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234531%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Marc Bischof

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234531%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Martha-Maria Gebhard

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234531%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Volker Ewerbeck

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234531%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Peter E Huber

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234531%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

23 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234531%20AND%20SRC:MED&resulttype=core&format=json

Strahlentherapie und Onkologie

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234531%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

187

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234531%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234531%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

45-51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234531%20AND%20SRC:MED&resulttype=core&format=json

Inhibition of alpha(v)beta3 integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Triple combination of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (SU5416) in human endothelial and tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

The cyclooxygenase-2 inhibitor nimesulide, a nonsteroidal analgesic, decreases the effect of radiation therapy in head-and-neck cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Synergy between celecoxib and radiotherapy results from inhibition of cyclooxygenase-2-derived prostaglandin E2, a survival factor for tumor and associated vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Targeting angiogenic processes by combination rofecoxib and ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Effects of lovastatin alone or combined with irradiation on tumor cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Combination of celecoxib with percutaneous radiotherapy in patients with localised prostate cancer - a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Trimodal cancer treatment: beneficial effects of combined antiangiogenesis, radiation, and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

The role of cyclooxygenase-2 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: an intravital microscopy study in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Efficacy of high dose per fraction radiation for implanted human prostate cancer in a nude mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Molecular targeted treatment and radiation therapy for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

SU11657 enhances radiosensitivity of human meningioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Efficacy of a triple treatment with irradiation, agonistic TRAIL receptor antibodies and EGFR blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Cyclooxygenase-2 modulates the insulin-like growth factor axis in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Prosthetic aortic valve replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Radiobiological investigation of dose-rate effects in intensity-modulated radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

COX-2 Inhibition Combined with Radiation Reduces Orthotopic Glioma Outgrowth by Targeting the Tumor Vasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Significant increase in residual DNA damage as a possible mechanism of radiosensitization by gemcitabine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

The role of cyclooxygenases in inflammation, cancer, and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Host cyclooxygenase-2 modulates carcinoma growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non–small-cell lung cancer: Long-term results of a radiation dose escalation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2116-3

Tyrosine kinase inhibitor SU6668 represses chondrosarcoma growth via antiangiogenesis in vivo

21 January 2018

1 reference

12 December 2020

Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer.

1 reference

12 December 2020

Effect of cyclooxygenase-2 (COX-2) inhibitors on prostate cancer cell proliferation.

1 reference

12 December 2020

Intraindividual comparison of conventional three-dimensional radiotherapy and intensity modulated radiotherapy in the therapy of locally advanced non-small cell lung cancer a planning study

1 reference

12 December 2020

COX-2-dependent stabilization of survivin in non-small cell lung cancer

1 reference

12 December 2020

Evaluation of cyclooxygenase-2 inhibition in an orthotopic murine model of lung cancer for dose-dependent effect

1 reference

12 December 2020

Radiation dose escalation combined with hormone therapy improves outcome in localised prostate cancer

1 reference

12 December 2020

Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.

1 reference

12 December 2020

Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy

1 reference

12 December 2020

Biological basis of radiation sensitivity. Part 2: Cellular and molecular determinants of radiosensitivity.

1 reference

12 December 2020

Enhancement of radiation sensitivity, delay of proliferative recovery after radiation and abrogation of MAPK (p44/42) signaling by imatinib in glioblastoma cells.

1 reference

12 December 2020

Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells

1 reference

12 December 2020

Cyclooxygenase in biology and disease

1 reference

12 December 2020

SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro

1 reference

12 December 2020

Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor

1 reference

12 December 2020

A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.

1 reference

12 December 2020

Ionizing radiation inhibits tumor neovascularization by inducing ineffective angiogenesis

1 reference

12 December 2020

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

1 reference

12 December 2020

Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo

1 reference

12 December 2020

A novel model for the investigation of orthotopically growing primary and secondary bone tumours using intravital microscopy

1 reference

12 December 2020

Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer

1 reference

12 December 2020

Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor

1 reference

12 December 2020

10.1007/S00066-010-2116-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234531%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference